ECSP003755A - COMBINATION CHEMOTHERAPY - Google Patents

COMBINATION CHEMOTHERAPY

Info

Publication number
ECSP003755A
ECSP003755A ECSP003755A ECSP003755A EC SP003755 A ECSP003755 A EC SP003755A EC SP003755 A ECSP003755 A EC SP003755A EC SP003755 A ECSP003755 A EC SP003755A
Authority
EC
Ecuador
Prior art keywords
combination chemotherapy
combination
chemotherapy
acetyldinaline
carboplatin
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Wayne Daniel Klohs
Ronald Lynn Merriman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003755 priority Critical patent/ECSP003755A/en
Publication of ECSP003755A publication Critical patent/ECSP003755A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La acetildinalina en combinación con paclitaxel y/o carboplatina es sinergistica para tratar el cáncer.Acetyldinaline in combination with paclitaxel and / or carboplatin is synergistic to treat cancer.

ECSP003755 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY ECSP003755A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003755 ECSP003755A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003755 ECSP003755A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Publications (1)

Publication Number Publication Date
ECSP003755A true ECSP003755A (en) 2001-03-22

Family

ID=42041328

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003755 ECSP003755A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Country Status (1)

Country Link
EC (1) ECSP003755A (en)

Similar Documents

Publication Publication Date Title
AR028296A1 (en) SYNERGISTIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
UY28213A1 (en) NEW CYANOPIRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS.
FR2869231B1 (en) THERAPEUTIC COMPOSITION CONTAINING AT LEAST ONE PYRROLOBENZODIAZEPINE DERIVATIVE AND FLUDARABINE
DE69903458D1 (en) CHEMOTHERAPY OF CANCER WITH ACETYLDINALINE IN COMBINATION WITH GEMCITABIN, CAPECITABIN OR CISPLATIN
NO20080442L (en) Phosphoramidate alkylator promoter
MXPA05012421A (en) Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents.
ATE281431T1 (en) RESORCIN DERIVATIVES
BRPI0507463A (en) use of glufosfamide and gemcitabine, product, and, combination of glufosfamide and gemcitabine
AR044039A1 (en) ANTINEOPLASIC COMBINATIONS
PA8506201A1 (en) COMBINATION CHEMOTHERAPY (COMBINATION CHEMOTHERAPY)
NO20050640L (en) Ruthenium anticancer complexes
EA200200808A1 (en) MODIFIED CYTOKINES INTENDED FOR USE IN CANCER TREATMENT
BR0114430A (en) Processes for cancer cell death induction and tumor regression
DE602004014787D1 (en) ANTI-TUMORAL FORMULATIONS WITH DEFIBROTIDE ALONE OR IN COMBINATION WITH OTHER ANTITUMOROUS AGENTS
ECSP003755A (en) COMBINATION CHEMOTHERAPY
TR200302193T4 (en) Combination chemotherapy.
DOP2000000092A (en) COMBINATION CHEMOTHERAPY
AR029451A1 (en) A COMPOSITION FOR USE IN THE BREAST CANCER THERAPY IN HUMAN BEINGS AND A PRODUCT FOR USE IN SUCH THERAPY
AR029958A1 (en) USE OF STRAMUSTIN PHOSPHATE IN THE TREATMENT OF OSEA METASTASIS AND IN THE TREATMENT OF OSEA METASTASIS IN PATIENTS WITH PROSTATE CANCER
BRPI0417513A (en) chp-gemcitabine combined agents and their use as active antitumor substances
DE60134740D1 (en) COMPOSITION FOR POTENTIATING CANCER CHEMOTHERAPEUTIC
MXPA04000418A (en) Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines.
UY29136A1 (en) USE OF EPOTILONES IN THE TREATMENT OF OSEA METASTASIS
ECSP982458A (en) ORAL APPLICATION OF (+) - O- DEMETILTRAMADOL AS AN ANALGESIC
DOP2003000674A (en) THERAPEUTIC COMBINATIONS OF ERB B QUINASA INHIBITORS AND ANTINEOOLASIC THERAPIES